Clinical Trial Update: Low-Flow CO2 Removal for Mild to Moderate ARDS With PRISMALUNG

View source ↗

Summary

Clinical trial update for low-flow CO2 removal using the PRISMALUNG device in mild to moderate acute respiratory distress syndrome; the study (NCT02606240) has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• PrismaLung+

Snippet

Sponsor: Groupe Hospitalier Pitie-Salpetriere | Conditions: Acute Respiratory Distress Syndrome | Status: COMPLETED